Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Regulation through Postfeminist Pharmacy 123<br />
to appear on grocery and drug store shelves, and numerous PMS-related<br />
greeting cards, buttons, bumper stickers, self-help books, and clothing<br />
appeared at <strong>the</strong> same time. Figert refers to <strong>the</strong> appearance of such items<br />
as <strong>the</strong> constitution of <strong>the</strong> “PMS industry” and notes that it was a cash<br />
cow, composed of <strong>the</strong> “3 Ps (products, pills, and prescriptions)” (p. 18).<br />
In a section entitled, “What’s at Stake in <strong>the</strong> Construction of PMS?”<br />
Figert argues that:<br />
for some women, <strong>the</strong> publicity and legitimization of PMS and its<br />
symptoms as real, a natural part of <strong>the</strong>ir body and its processes, have<br />
led to a positive sense of control over this phenomenon. However, a<br />
more negative image of PMS as something that controls women once<br />
a month, that makes <strong>the</strong>m “crazy” and subject to <strong>the</strong>ir hormones, is<br />
much more pervasive in our contemporary Western culture. This image<br />
has allowed women to use PMS as an excuse to express <strong>the</strong>ir emotions<br />
or to account for <strong>the</strong>ir o<strong>the</strong>rwise “strange” behaviors. O<strong>the</strong>r people<br />
(husbands, children, doctors, lawyers, judges, juries, co-workers) have<br />
also used PMS to explain women’s behaviors—often within a scientifi c<br />
or medical framework that <strong>the</strong>n gives physicians and scientists “expert”<br />
legitimacy over women’s bodies and minds. (p. 21)<br />
Following Figert (1996), we suggest that Sarafem’s emergence is one<br />
P in <strong>the</strong> 3 Ps Figert points to earlier, and one that was marketed both<br />
to attend to Eli Lilly’s exigencies and to recognize (however unknowingly)<br />
<strong>the</strong> regulatory potential of postfeminist discourse along with its<br />
importance as a commercial vehicle. Sarafem was marketed to <strong>the</strong> public<br />
using both television and print advertisements. One of <strong>the</strong> two television<br />
advertisements (Eli Lilly had produced three, but <strong>the</strong> fi rst was deemed<br />
by <strong>the</strong> Food and Drug Administration to be too aggressive) included<br />
two brief but dramatic and silent vignettes, each of which conveyed<br />
<strong>the</strong> frustration of experiencing PMDD. In <strong>the</strong> fi rst, a woman storms<br />
around her house, fi nally violently throwing a pillow against a couch.<br />
As her male lover or husband follows her into this room, she looks at<br />
him and <strong>the</strong>n appears to yell; his face shows his bewilderment and his<br />
stance—arms crossed in front of his chest—signifi es his hostility toward<br />
her. The second vignette occurs in <strong>the</strong> dressing room of a clothing store<br />
where a woman is trying on clo<strong>the</strong>s and fi nding everything too tight,<br />
apparently because of premenstrual bloating. Her expression reveals<br />
her exasperation about <strong>the</strong> experience, and she thrusts <strong>the</strong> clothing<br />
into <strong>the</strong> arms of <strong>the</strong> friendly-looking salesperson (also a woman). The<br />
voiceover suggests that <strong>the</strong>se instances of irritability and mood swings<br />
could be even more severe than a simple case of PMS: “Think again. It